Gilvetmab is a caninized anti-PD-1 monoclonal antibody designed to exhibit potent inhibitory effects on the PD-1/PD-L1 interaction. By blocking this pathway, Gilvetmab effectively disrupts a critical immune checkpoint mechanism, thereby enhancing T-cell function and immune response against tumor cells. This antibody is specifically tailored for use in research related to malignant melanoma, providing a valuable tool for investigating the role of the PD-1/PD-L1 pathway in cancer immunotherapy.
Gilvetmab is a caninized anti-PD-1 monoclonal antibody designed to exhibit potent inhibitory effects on the PD-1/PD-L1 interaction. By blocking this pathway, Gilvetmab effectively disrupts a critical immune checkpoint mechanism, thereby enhancing T-cell function and immune response against tumor cells. This antibody is specifically tailored for use in research related to malignant melanoma, providing a valuable tool for investigating the role of the PD-1/PD-L1 pathway in cancer immunotherapy.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
